EUVIMEDEUVIMED entdecken
Crossref

An Underlying Cause and Solution to the Poor Size Exclusion Chromatography Performance of Antibody–Drug Conjugates

Jian-Zhong Liu, Chao-Yang Du, Han Gao, Haibin Wang, Feng Hu, Wei-Jie Fang

Pharmaceutical Research · 2024-12 · 41 (12) · 2299-2317

DOI: 10.1007/s11095-024-03796-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, online erschienen am 13.12.2024. Verfasst von Jian-Zhong Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. Hauptthemen laut MEDLINE: Immunoconjugates, Chromatography, Gel, Hydrophobic and Hydrophilic Interactions, Antibodies, Monoclonal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China, Jinhua Science and Technology Plan Projects, Municipal-University Cooperation Projects of Taizhou Institute of Zhejiang University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSES: Antibody-drug conjugate (ADC) size variants are frequently assessed by size exclusion chromatography (SEC). However, poor chromatography performance is often observed during SEC analysis. Existing studies have primarily focused on qualitatively describing non-specific interactions between ADCs and the column matrix. The purposes of the current study are to introduce an underlying cause from a novel perspective on the protein-protein interaction (PPI) mechanism, characterized by quantifying diffusion interaction parameter (kD) values, and to provide several strategies to reduce PPI and improve column performance during SEC analysis. METHODS: Two kinds of ADCs with varying hydrophobicity properties and their corresponding monoclonal antibodies are used as models. The hydrophobicity of these products was verified using the relative calculated logarithm of the partition coefficient of a substance in n-octanol (oil) and water (rCLogP) and reversed-phase high performance liquid chromatography (RP-HPLC), and the size variants were analyzed using SEC. Finally, the PPI was characterized by kD values of these four products. RESULTS: The results of rCLogP and RP-HPLC indicated that ADC-1 is relatively hydrophobic, whereas ADC-2 is relatively hydrophilic. In the SEC analysis of the ADC-1, substituting sodium chloride with L-arginine hydrochloride or adding a specific concentration of acetonitrile as an organic solvent to the mobile phase resulted in reduced PPI and enhanced column performance. Conversely, the impact on ADC-2 was negligible. CONCLUSIONS: This study provides insights into improving the performance of SEC analysis for ADCs through strategies involving alterations in mobile phase composition. The changes in column performance can be quantitatively explained by the PPI mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesChromatography, GelHydrophobic and Hydrophilic InteractionsAntibodies, MonoclonalChromatography, High Pressure LiquidChromatography, Reverse-PhaseArginineAcetonitriles

Stichwörter der Autor:innen

Antibody-drug conjugateColumn performance optimizationMonoclonal antibodyProtein-protein interactionReversible self-associationSize exclusion chromatography

Substanzen

ImmunoconjugatesAntibodies, MonoclonalArginineAcetonitrilesacetonitrile

Autor:innen und Institutionen

  • Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
  • Taizhou Institute of Zhejiang University, Taizhou, 317000, China.
  • Innovation Center of Translational Pharmacy, Jinhua Institute of Zhejiang University, Jinhua, 321000, China.
  • Zhejiang Bioray Biopharmaceutical Co., Taizhou, 317000, China.
  • Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. wjfang@zju.edu.cn.
  • Taizhou Institute of Zhejiang University, Taizhou, 317000, China. wjfang@zju.edu.cn.

Förderung

  • Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China
  • Jinhua Science and Technology Plan Projects
  • Municipal-University Cooperation Projects of Taizhou Institute of Zhejiang University
  • Scientific Research Fund of Zhejiang University
  • Taizhou Science and Technology Plan Projects

Zitieren

APA

Liu, J. Z., Du, C. Y., Gao, H., Wang, H., Hu, F., & Fang, W. J. (2024). An Underlying Cause and Solution to the Poor Size Exclusion Chromatography Performance of Antibody–Drug Conjugates. Pharmaceutical Research, 41(12), 2299-2317. https://doi.org/10.1007/s11095-024-03796-x

Vancouver

Liu JZ, Du CY, Gao H, Wang H, Hu F, Fang WJ. An Underlying Cause and Solution to the Poor Size Exclusion Chromatography Performance of Antibody–Drug Conjugates. Pharmaceutical Research. 2024;41(12):2299-2317. doi:10.1007/s11095-024-03796-x

BibTeX
@article{Liu2024,
  author = {Liu, Jian-Zhong and Du, Chao-Yang and Gao, Han and Wang, Haibin and Hu, Feng and Fang, Wei-Jie},
  title = {An Underlying Cause and Solution to the Poor Size Exclusion Chromatography Performance of Antibody–Drug Conjugates},
  journal = {Pharmaceutical Research},
  year = {2024},
  volume = {41},
  number = {12},
  pages = {2299--2317},
  doi = {10.1007/s11095-024-03796-x}
}
Kostenlos starten →